ESC 365 - Doctor Hirotoshi Watanabe

Speaker illustration

Doctor Hirotoshi Watanabe

Hirakata Kohsai Hospital, Hirakata (Japan)

Member of:

Post-PCI anticoagulation with unfractionated heparin in acute coronary syndrome: insight from the STOPDAPT-3 trial

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Tailored approaches to cardiovascular therapy in acute coronary syndromes

Clopidogrel following 1-month aspirin-free low-dose prasugrel monotherapy versus aspirin following 1-month DAPT after PCI for patients with ACS or HBR: Final 1-year results from the STOPDAPT-3

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Trial updates and other studies on percutaneous coronary intervention

STOPDAPT-2 ACS: one-month dual antiplatelet therapy followed by clopidogrel monotherapy in acute coronary syndrome

Event: ESC Congress 2021 - The Digital Experience

Topic: Adjunctive Pharmacotherapy

Session: Hot Line - STOPDAPT-2 ACS

Post-discharge myocardial infarction after percutaneous coronary intervention: incidence, risk factors, size distribution and its prognostic significance

Event: ESC Congress 2017

Topic: PCI: long-term outcome

Session: PCI - Long-term outcome

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources